Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Product Guide
Posts
Blog Post
Clinical Trial Alert: Catabasis Seeks Participants for a Phase 3 DMD Study
By
MDA Staff
|
January 10, 2019
Blog Post
Wave Life Sciences Announces Phase 2/3 Duchenne Muscular Dystrophy Clinical Trial of Suvodirsen (WVE-210201) Selected for FDA Complex Innovative Trial Designs Pilot Program
By
Jeanene Swanson
|
January 8, 2019
Blog Post
FDA Grants Orphan Drug Designation to Myonexus Therapeutics’ MYO-102 Gene Therapy Drug for Limb-Girdle Muscular Dystrophy Type 2D
By
Jeanene Swanson
|
January 4, 2019
Blog Post
FDA Announces the Approval of TIGLUTIK, an Oral Suspension Form of riluzole, for the Treatment of ALS
By
MDA Staff
|
September 10, 2018
Blog Post
From Graduation Onward: MDA National Ambassador Justin Moy Looks Ahead
By
Justin Moy
|
June 14, 2018
Featured Article
Sparking the Live Unlimited Spirit
By
MDA Staff
|
June 30, 2017
Blog Post
FDA Approves Radicava to Treat ALS
By
Amy Madsen
|
May 6, 2017
Blog Post
Risky Business: Nongenetic Factors May Increase Odds of Developing ALS
By
Amy Madsen
|
February 3, 2013
Featured Article
Portable Lifts A Real Pick Me Up for Caregivers
By
MDA Staff
|
September 30, 2012
Blog Post
When the Thinking Parts of the Brain Go Awry in ALS
By
Amy Madsen
|
October 31, 2011
« Previous
1
…
83
84
85
86
87
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset